P. Teo
Impact in
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies
- Oncology top 5%
- Viral-associated cancers and disorders
- Ear and Head Tumors
Papers in
-
- Head and Neck Cancer Studies 21
- Surgery 17
- Head and Neck Surgical Oncology 12
- Salivary Gland Tumors Diagnosis and Treatment 3
- Co-authors
- S. F. Leung (9 shared papers)W. H. Kwan (12 shared papers)Philip J. Johnson (8 shared papers)Peter Choi (8 shared papers)W. Y. Lee (5 shared papers)Kam Yu (4 shared papers)Peter S. Y. Yu (7 shared papers)W. Shiu (5 shared papers)
In The Last Decade
P. Teo
35 papers receiving 1.6k citations
P. Teo's Hit Papers
Peers
Comparison fields: 5 of 67
- Otorhinolaryngology 929
- Oncology 455
- Cancer Research 155
- Surgery 397
- Pulmonary and Respiratory Medicine 196
Countries citing papers authored by P. Teo
This map shows the geographic impact of P. Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Teo more than expected).
Fields of papers citing papers by P. Teo
This network shows the impact of papers produced by P. Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Teo. The network helps show where P. Teo may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Teo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial Hit paper breakdown → | 2002 | 374 |
| 2 | High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. | 2001 | 243 |
| 3 | 1996 | 187 | |
| 4 | High resolution allelotype of microdissected primary nasopharyngeal carcinoma. | 2000 | 132 |
| 5 | Clinical features and management of distant metastases of nasopharyngeal carcinoma. | 1991 | 78 |
| 6 | 1992 | 71 | |
| 7 | 1999 | 59 | |
| 8 | 2000 | 47 | |
| 9 | 2003 | 46 | |
| 10 | 1996 | 44 | |
| 11 | 2000 | 41 | |
| 12 | 2004 | 39 | |
| 13 | 2001 | 33 | |
| 14 | 1993 | 30 | |
| 15 | 1994 | 28 | |
| 16 | Failure patterns and factors affecting prognosis of salivary gland carcinoma: retrospective study. | 2000 | 26 |
| 17 | 1996 | 26 | |
| 18 | 1991 | 20 | |
| 19 | 1989 | 20 | |
| 20 | 1994 | 18 |
About P. Teo
P. Teo is a scholar working on Otorhinolaryngology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.7k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (21 papers), Head and Neck Surgical Oncology (12 papers), Ear and Head Tumors (7 papers), Cancer Diagnosis and Treatment (3 papers), Lung Cancer Research Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Otorhinolaryngology (929 citations), Oncology (455 citations), Cancer Research (155 citations), Surgery (397 citations) and Pulmonary and Respiratory Medicine (196 citations). P. Teo has collaborated with scholars based in China, Hong Kong and Malaysia. Frequent co-authors include S. F. Leung, W. H. Kwan, Philip J. Johnson, Peter Choi, W. Y. Lee, Kam Yu, Peter S. Y. Yu, W. Shiu, Thomas W. T. Leung and Ka‐Fai To. Their work appears in journals such as Clinical Oncology, Journal of Clinical Oncology, British Journal of Radiology, International Journal of Radiation Oncology*Biology*Physics and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.